Published in Cancer Weekly, May 8th, 2001
Y. Wang and colleagues created antisense uPAR-expressing vectors encompassing either the 3' or 5' ends of uPAR mRNA. Vectors were transfected into HCT116, which is a colon cancer cell line with a high metastatic potential. After confirming transfection with DNA hybridization, clones were evaluated for receptor bound endogenous uPA activities and for extracellular matrix degradation.
In the April 2001 issue of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.